Back to Authors

She, Rosemary C.

https://orcid.org/0000-0002-8773-1687

A5010398581 | I1301076528

Mayo Clinic

City Of Hope National Medical Center

Citations 4

Diagnostic testing and laboratory equity in clinical microbiology

Microbiology Spectrum | June 25, 2024 | Volume: 12 | Issue: 8 | Pages: No page available

10.1128/spectrum.01222-24 | PMID 38916359

Considerations from the College of American Pathologists for Implementation of an Assay for SARS-CoV-2 Testing after a Change in Regulatory Status

Journal of Clinical Microbiology | July 14, 2021 | Volume: 59 | Issue: 10 | Pages: No page available

10.1128/jcm.01167-21 | PMID 34260276

The U.S. Food & Drug Administration (FDA) regulates the marketing of manufacturers’ in vitro diagnostic tests (IVDs), including assays for the detection of SARS-CoV-2.
College of American Pathologists (CAP) Microbiology Committee Perspective: Caution Must Be Used in Interpreting the Cycle Threshold (Ct) Value

Clinical Infectious Diseases | August 11, 2020 | Volume: 72 | Issue: 10 | Pages: e685-e686

10.1093/cid/ciaa1199 | PMID 32785682

College of American Pathologists (CAP) Microbiology Committee Perspective: the Need for Verification Studies

Journal of Clinical Microbiology | March 24, 2020 | Volume: 58 | Issue: 4 | Pages: No page available

10.1128/jcm.02105-19 | PMID 32213579